Directory → Organotropona funds → Respiratory funds → Secretolitiki stimulants and motor function airways → Bromgexin-ferein
This page is translated automatically with a help of Google Translate
Bromgexin-fereinSee also BromhexineRoman nameBromhexin-FereinThe composition and the form of5 ml syrup contain bromgexina 4 mg; in the glass bottle for 60 or 100 ml, in a cardboard bundle one bottle complete with measuring spoon.Of drugsMukoliticescoe, skin, protivokashlevoe. Depolimerizuet acid polysaccharides rate and stimulates cells secretorne mucous membrane bronchi which produce secret containing neutral polysaccharides, reduces viscosity Bronchus secret and make its selection.PharmacokineticsOnce inside almost entirely (99%) in rats for 30 min. Bioavailability of 80%, has been associated with the plasma protein passes through the GEB and placental barrier. Metabolised in the liver, partly with the formation of active metabolites. T_1/2 to one hour, the terminal phase-15 hrs (from the back diffusion of tissue). Report the news, with multiple application can koumoulirovati. Against the backdrop of severe liver klirens lowered, and in chronic kidney failure, broken down metabolites.IndicationsAcute and chronic inflammatory diseases of the lungs, accompanied by the formation of trudnootdelema viscous sputum (bronchial asthma, cystic fibrosis, tuberculosis, pneumonia, traheobronhit, obstruguy bronchitis, bronhoektaza, emphysema lung disorders), trauma chest.ContraindicationsHypersensitivity, I trimester of pregnancy, breast-feeding.Side-EffectsRarely, in a long reception, nausea, vomiting, diarrhoea phenomenon worsening ulcers stomach and duodenal ulcers, raising transaminaz in the serum, allergic reactions (skin rash, myalgia, etc.).Specific guidanceAppointment against ulcers or stomach patients with stomach bleeding in the history warrant further medical controls.Patient interactionProducts containing codeine impair releases razzyzenna patients. Is penetration of antibiotics, including tetracycline, erythromycin, and cefalexin sulfanilamidov in the mucous membrane of bronchus and lung tissue.Dosing and AdministrationInside (regardless of meals), adults and children over 14 years in the 8-16 mg (c.logki 2-4), 3 times a day, children between 6 and 14 years in the 4-8 mg (1-2 c.logki) three times a day; children from 2 to 6 years in the 2-4 mg (1/2-1 c.lojka) three times a day for children up to 2 years to 2 mg (1 / 2 c.logki) three times a day. The course of treatment is from 4 to 28 days. The treatment is recommended to use enough liquid.Storage conditionssyrup : List B. In cool the dark spotShelf lifesyrup : 2 grams. |
All products of this group |

